Definitive Contract 75N95019C00007
Award Date
12/13/18
Potential Completion Date
12/15/23
Potential Value
$7.2M
Federal Agency
National Institute on Drug Abuse
Awardee
The Mclean Hospital Corporation
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Belmont, MA 02478, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $20,246,653 definitive cost-no-fee contract awarded by the National Institute on Drug Abuse (NIDA) to The McLean Hospital Corporation to assess potential substance abuse treatment medications using non-human primate models. The contract does not have a set-aside designation. The contract supports NIDA's Addiction Treatment Discovery Program (ATDP), which evaluates compounds for their potential to treat drug addiction by assessing effects on drug discrimination, self-administration, and...
This is a $5,833,141.44 cost-reimbursable contract awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Virginia Commonwealth University (VCU) for medication discovery research using rat models of drug relapse. The contract has a period of performance from July 10, 2019 to July 9, 2024, with the initial award covering the first year. This contract was awarded under a competitive solicitation that was open to small businesses only, but no...
The Department of Justice Drug Enforcement Administration (DEA) awarded a $136,383.00 firm fixed price purchase order to The Mclean Hospital Corporation, a non-profit research hospital affiliated with Harvard Medical School, to conduct a study on the drug discrimination and locomotor activity of 15 designer benzodiazepine substances. This study aims to gather pharmacological, medical, and epidemiological data to support the DEA's efforts to place these substances under regulatory control under...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health, to Med Associates, Inc., a for-profit, woman-owned small business manufacturer and supplier of specialized scientific laboratory equipment and software. The contract award, valued at $18,898.50, is for the delivery of products that support research into substance use disorders, neurological processes, addiction mechanisms, and behavioral...
This is a cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Virginia Commonwealth University (VCU) for $11,354,157.46. The contract is for preclinical medication discovery and abuse liability testing services in support of NIDA's mission. The contract has a period of performance from February 22, 2017 to February 21, 2018, with a potential completion date of February 16, 2025. This award is not...
This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute on Drug Abuse to Med Associates, Inc. for $25,745.15. The contract calls for Med Associates to deliver smart control modules and accessories within 45 days to support the NIDA IRP's Behavioral Neuroscience and Neuropsychiatry Section laboratory in Baltimore, Maryland. Per the original solicitation, the modules and accessories will be used for animal behavioral research procedures simulating...
The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $12,087 purchase order to Med Associates, Inc., doing business as Med Associates, for unspecified services or products. The contract has a one-year period of performance beginning July 7, 2023 through July 6, 2024 and utilizes a firm fixed price contracting structure. Place of performance will be Med Associates' Baltimore, Maryland location. No additional details were...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services. The $19,910.40 firm fixed-price purchase order was awarded to Med Associates, Inc., a for-profit, woman-owned small business manufacturer of specialized scientific laboratory equipment and software. The contract is for the delivery of a SMARTCTRL 8-input/16-output package to replace retiring Coulbourn equipment that is essential for ongoing...
This is a grant award from the National Aeronautics and Space Administration (NASA) to The Mclean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with Harvard Medical School. The $449,956.00 grant will fund research to delineate the effects of combined exposure to space radiation and sleep fragmentation on brain neurochemistry and cognition. The grant has a performance period ending on November 17, 2027. The Mclean Hospital Corporation is a leading research...
This federal contract award, valued at $97,958.43, was made by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, to Med Associates, Inc., a for-profit, woman-owned manufacturer of scientific research equipment. The contract is for the delivery of modular operant conditioning and general behavior chambers for rats, which enable NIDA to conduct animal studies examining the behavioral and biological mechanisms underlying substance use...